These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35359037)

  • 1. [Pay attention to the detection and evaluation of CD30 in pathological diagnosis of lymphoma].
    Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):287-289. PubMed ID: 35359037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis.
    Xu ML; Gabali A; Hsi ED; Fedoriw Y; Vij K; Salama ME; Ramchandren R; O'Malley D; Wick MR; Battistella M; Gru AA
    Am J Surg Pathol; 2020 Feb; 44(2):e1-e14. PubMed ID: 31567279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 Cross-Reactivity and Expression in Feline Normal Tissues and Lymphomas.
    Carminato A; Tecilla M; Roccabianca P; Zanardello C; Melchiotti E; Capello K; Vascellari M
    Vet Pathol; 2020 Jan; 57(1):49-55. PubMed ID: 31640480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
    Debliquis A; Baseggio L; Bouyer S; Guy J; Garnache-Ottou F; Genevieve F; Mayeur-Rousse C; Letestu R; Chapuis N; Harrivel V; Bennani H; Lachot S; Loosveld M; Nicolino-Brunet C; Pérès M; Roussel M; Veyrat-Masson R; Jacob MC; Drenou B
    Cytometry B Clin Cytom; 2021 Jul; 100(4):488-496. PubMed ID: 32803917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.
    Paulli M; Berti E; Boveri E; Kindl S; Bonoldi E; Gambini C; Rosso R; Borroni G; Straccapansa V; Magrini U; DeCoteau JE; Krammer PH; Möller P; Kadin ME
    Hum Pathol; 1998 Nov; 29(11):1223-30. PubMed ID: 9824099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.
    Gruss HJ; Boiani N; Williams DE; Armitage RJ; Smith CA; Goodwin RG
    Blood; 1994 Apr; 83(8):2045-56. PubMed ID: 8161776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus-encoded RNAs.
    Kim EK; Yang WI; Ryu HJ; Ji HL; Yoon SO
    Adv Anat Pathol; 2020 Mar; 27(2):75-86. PubMed ID: 31913182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
    Rinaldi I
    Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of driving CD30-directed CAR-T cells to the clinic.
    Grover NS; Savoldo B
    BMC Cancer; 2019 Mar; 19(1):203. PubMed ID: 30841880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of CD30 Expression in Aggressive B-Cell Lymphomas.
    Malysz J; Erdman P; Klapper J; Zhu J; Creer M; Bayerl MG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):429-33. PubMed ID: 27521276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and a role of CD30 in regulation of T-cell activity.
    Tarkowski M
    Curr Opin Hematol; 2003 Jul; 10(4):267-71. PubMed ID: 12799531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
    Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
    Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family.
    Schneider C; Hübinger G
    Leuk Lymphoma; 2002 Jul; 43(7):1355-66. PubMed ID: 12389614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
    Falini B; Pileri S; Stein H; Dieneman D; Dallenbach F; Delsol G; Minelli O; Poggi S; Martelli MF; Pallesen G
    Hum Pathol; 1990 Jun; 21(6):624-9. PubMed ID: 1693592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.
    Kumar S; Kunec D; Buza JJ; Chiang HI; Zhou H; Subramaniam S; Pendarvis K; Cheng HH; Burgess SC
    BMC Syst Biol; 2012 Sep; 6():123. PubMed ID: 22979947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30
    Wang R; Li L; Zhang S; Li Y; Wang X; Miao Q; Zhen Y
    Mol Oncol; 2018 Mar; 12(3):339-355. PubMed ID: 29316337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
    Michai M; Goto H; Hattori S; Vaeteewoottacharn K; Wongkham C; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2012; 13(10):4939-41. PubMed ID: 23244086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas.
    Karube K; Kakimoto Y; Tonozuka Y; Ohshima K
    Expert Rev Hematol; 2021 Aug; 14(8):777-787. PubMed ID: 34263699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30 antigen in non-Hodgkin's lymphoma.
    Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
    Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.